A national treatment survey on the chemotherapy (CTX) treatment for patients (Pts) with metastatic breast cancer (MBC) in Germany.
Christian Jackisch
Consultant or Advisory Role - Roche
Michael Untch
No relevant relationships to disclose
Peter Dall
No relevant relationships to disclose
Christoph Thomssen
No relevant relationships to disclose
Ute-Susann Albert
No relevant relationships to disclose
Hans-Joachim Lueck
Honoraria - Celgene; Novartis; Roche
Ingo Bauerfeind
Honoraria - Bristol-Myers Squibb; Celgene; Eisai; Roche
Anton J. Scharl
No relevant relationships to disclose